Lobbying

Rxfunction's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2024; the issues it reports most are Medicare/Medicaid.

Rxfunction

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2024
The first quarter a report named it

Lobbying by quarter

Rxfunction lobbying by quarter
Rxfunction lobbying by quarter
QuarterAmountReports
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Medicare and Medicaid$40K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
Federal Health Policy Strategies$80K7 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q2Federal Health Policy StrategiesUnder $5,000
04/20for Q1Federal Health Policy StrategiesUnder $5,000
01/20for Q4 2025Federal Health Policy StrategiesUnder $5,000
25/10/20for Q3 2025Federal Health Policy Strategies$20K
25/07/21for Q2 2025Federal Health Policy Strategies$20K
25/04/18for Q1 2025Federal Health Policy Strategies$20K
25/01/21for Q4 2024Federal Health Policy Strategies$20K
25/01/15for Q4 2024Federal Health Policy StrategiesUnder $5,000